Citation, DOI, disclosures and article data
At the time the article was created Frank Gaillard had no recorded disclosures.View Frank Gaillard's current disclosures
At the time the article was last revised Calum Worsley had no recorded disclosures.View Calum Worsley's current disclosures
Craniopharyngioma is a term used to denote two separate entities (adamantinomatous craniopharyngiomas and papillary craniopharyngiomas), both relatively benign (WHO grade 1) neoplasms that typically arise in the sellar/suprasellar region.
Increasing molecular evidence has demonstrated that they have distinct and mutually exclusive mutations of CTNNB1 (adamantinomatous) and BRAF (papillary).
As such, they are now considered separate entities and will be discussed separately.